Vous êtes sur la page 1sur 22

19-09-2014

19
th
September, 2014 Volume No.: 37 Issue No.: 04
Vision
TO REACH THE PINNACLE OF GLORY AS A CENTRE OF EXCELLENCE IN THE FIELD
OF PHARMACEUTICAL AND BIOLOGICAL SCIENCES BY KNOWLEDGE BASED
LEARNING AND PRACTICE
Contents
Message from PRINCIPAL
Editorial board
Historical article
News Update
Knowledge based Article
Disease Related Breaking
News
Upcoming Events
Drugs Update
Campus News
Students Section
Editors Note
Archive
GNIPST Photo Gallery
For your comments/contribution
OR For Back-Issues,
mailto:gnipstbulletin@gmail.com
GURU NANAK INSTITUTE OF PHARMACEUTICAL
SCIENCE AND TECHNOLOGY

We

b

si

t

e

:



ht

t

p:

/

/

gni

ps

t.

a

c.

i

n



19-09-2014
MESSAGE FROM PRINCIPAL

"It can happen. It does happen.
But it can't happen if you quit." Lauren Dane.
We are what we repeatedly do.
Excellence then is not an act, but a habit. Aristotle
It gives me immense pleasure to pen a few words for our e-bulletin. At the onset I would like to thank the
last years editors and congratulate the newly selected editors for the current year.
Our first consideration is always in the best interest of the students. Our goal is to promote academic
excellence and continuous improvement.
I believe that excellence in education is aided by creating a learning environment in which all learners are
supported in maximizing their potential and talents. Education needs to focus on personalized learning
and instruction, while promoting an education system that is impartial, universally accessible, and meeting
the needs of all students.
It is of paramount importance that our learners have sufficient motivation and encouragement in order to
achieve their aims. We are all very proud of you, our students, and your accomplishments and look
forward to watching as you put your mark on the profession in the years ahead.
The call of the time is to progress, not merely to move ahead. Our progressive Management is looking
forward and wants our Institute to flourish as a Post Graduate Institute of Excellence. Steps are taken in
this direction and fruits of these efforts will be received by our students in the near future. Our Teachers
are committed and dedicated for the development of the institution by imparting their knowledge and play
the role of facilitator as well as role model to our students.
The Pharmacy profession is thriving with a multitude of possibilities, opportunities and positive
challenges. At Guru Nanak Institute of Pharmaceutical Science and Technology, our focus is on holistic
needs of our students.
I am confident that the students of GNIPST will recognize all the possibilities, take full advantage of the
opportunities and meet the challenges with purpose and determination.
Excellence in Education is not a final destination, it is a continuous walk. I welcome you to join us on
this path.
My best wishes to all.
Dr. A. Sengupta
Click here to go at the top
1
19-09-2014
EDITORIAL BOARD
CHIEF EDITOR DR. ABHIJIT SENGUPTA
EDITOR MS. JEENATARA BEGUM
ASSOCIATE EDITOR MR. DIPANJAN MANDAL
HISTORICAL ARTICLE
Damian and Cosmas Pharmacys Patron Saints:
Twinship of the health professions, Pharmacy and Medicine, is
nowhere more strikingly portrayed than by Damian, the
apothecary, and Cosmas, the physician. Twin brothers of Arabian
descent, and devout Christians, they offered the solace of religion
as well as the benefit of their knowledge to the sick who visited
them. Their twin careers were cut short in the year 303 by
martyrdom. For centuries their tomb in the Syrian city of Cyprus
was a shrine. Churches were built in their honor in Rome and
other cities. After canonization, they became the patron saints of
Pharmacy and Medicine, and many miracles were attributed to
them.
NEWS UPDATE
16
th
September: International Day for the
Preservation of the Ozone Layer:
The International Ozone Day is an annual event that
commemorates the date of the signing, in 1987, of the Montreal
Protocol. The theme for the 2014 celebrations highlighted the fact
that efforts to protect the ozone layer continue in earnest and
encouraged action to address future challenges.
Click here to go at the top
2
19-09-2014

Sibling bullying linked to later depression, self-
harm: (19
th
September, 2014)
A new study has found that children who revealed they had been
bullied by their brothers or sisters several times a week or more
during early adolescence were twice as likely to report being
clinically depressed as young adults.
Mitochondria's role in neurodegenerative
diseases clearer thanks to mouse study: (19
th

September, 2014)
A new study sheds light on a longstanding question about the role
of mitochondria in debilitating and fatal motor neuron diseases
and resulted in a new mouse model to study such illnesses.
Mitochondria are organelles -- compartments contained inside
cells -- that serve several functions, including making ATP, a
nucleotide that cells convert into chemical energy to stay alive. For
this reason mitochondria often are called "cellular power plants."
Wireless sensor transmits tumor pressure: (19
th

September, 2014)
A novel sensor that can wirelessly relay pressure readings from
inside a tumor has been developed by researchers. The interstitial
pressure inside a tumor is often remarkably high compared to
normal tissues and is thought to impede the delivery of
chemotherapeutic agents as well as decrease the effectiveness of
radiation therapy. While medications exist that temporarily
decrease tumor pressure, identifying the optimal window to
initiate treatment -- when tumor pressure is lowest -- has
remained a challenge.
Click here to go at the top

3
19-09-2014

Premature deaths could be reduced by 40% over
next 20 years, researchers say: (19
th

September, 2014)
With sustained international efforts, the number of premature
deaths could be reduced by 40% over the next two decades (2010-
2030), researchers say, halving under50 mortality and preventing
a third of the deaths at ages 5069 years.
New biomedical implants heal bones faster,
focus on personalized medicine: (18
th

September, 2014)
A major success in developing new biomedical implants with the
ability to accelerate bone healing has been reported by a group of
scientists, which suggests a move toward a future of personalized
products. "It is very much like your taste in music and TV shows.
People are different and the new trend in biotechnology is to make
personalized medicine that matches the patient's needs," he says.
"With regard to implants, we have the problem of variations in
bone density in patients with osteoporosis and in some cases, even
healthy individuals."
Tolerating, not fighting, viruses a viable survival
strategy: (18
th
September, 2014)
In ecology, disease tolerance is defined as a host strategy not to
fight a pathogen tooth and nail, but rather tolerate it to live (and
survive) better in the long term. One key feature of tolerance is
that the disease only progresses very slowly -- if at all -- even if the
host carries a high pathogen load. In some HIV sufferers, this
approach is evident. A research team has now determined how
strongly patients differ in their tolerance and upon which factors it
depends.
Click here to go at the top

4
19-09-2014


Melanoma risk found to have genetic
determinant: (18
th
September, 2014)
Longer telomeres increase the risk of melanoma, researchers
report, suggesting that melanoma risk has a genetic determinant.
Telomeres are a part of the genome that function like the plastic
caps of your shoelaces, which prevent the laces from fraying.
Instead they protect the ends of chromosomes from environmental
damage, such as exposure to smoke or sunlight, which can harm
them.
New microscopy technique yields fresh data on
muscular dystrophy: (18
th
September, 2014)
A new microscopy technique yields resolution an order of
magnitude better than previously possible. Through this new
technique, the researchers showed that dystrophin was
responsible for regulating tiny molecular fluctuations in calcium
channels while muscles are in use. The discovery suggests that a
lack of functional dystrophin alters the dynamics of ion channels --
helping to cause the defective mechanical responses and the
calcium imbalance that impair normal muscle activity in patients
with muscular dystrophy.
Enzyme attacks synaptic molecule, leading to
cognitive impairment: (18
th
September, 2014)
Researchers have just highlighted a fundamental synaptic
mechanism that explains the relationship between chronic stress
and the loss of social skills and cognitive impairment. When
triggered by stress, an enzyme attacks a synaptic regulatory
molecule in the brain, leading to these problems.


Click here to go at the top

5
19-09-2014

Spontaneous mutations in key brain gene are a
cause of autism, study concludes: (18
th

September, 2014)
Spontaneous mutations in the brain gene TBR1 disrupt the
function of the encoded protein in children with severe autism. In
addition, there is a direct link between TBR1 and FOXP2, a well-
known language-related protein, researchers report.
Wild berry extract may strengthen
effectiveness of pancreatic cancer drug: (17
th

September, 2014)
A wild berry native to North America may strengthen the
effectiveness of a chemotherapy drug commonly used to treat
pancreatic cancer, reveals research. The study suggests that adding
nutraceuticals to chemotherapy cycles may improve the
effectiveness of conventional drugs, particularly in hard to treat
cancers, such as pancreatic cancer.

For detail mail to editor



KNOWLEDGE BASED ARTICLE
Omega 3 fatty acids and its role in treatment of
rheumatoid arthritis
Pathological conditions that end with the word itis indicates an
inflammation in that particular or surrounding area. For example if
we consider bronchitis- it is the inflammation of the bronchial tubes
or any part of them, similarly if we consider conjunctivitis- it is the
inflammation of the conjunctiva. So we can say arthritis is the
inflammation of the joints.
Click here to go at the top

6
19-09-2014

Rheumatoid arthritis is an autoimmune disorder that can cause
chronic inflammation of the joints.
Autoimmune diseases are illnesses that can occur when the body's
tissues are mistakenly diagnosed as foreign objects and are
attacked by their own immune system.
The immune system is made up of a complex colony of cells and
antibodies which are usually designed to "detect and destroy" the
foreign objects invading of the body, particularly infections.
The patients suffering from autoimmune diseases have specific
antibodies and immune cells in their blood that can target their
own body cells, where they can be associated with inflammation.
While inflammation of the tissue and around the joints is
characteristic features of rheumatoid arthritis, this disease can also
cause inflammation and injury in other organs of the body.
As because it can affect multiple other organs of the body,
rheumatoid arthritis is referred to as a systemic illness and is
sometimes called rheumatoid disease.
Rheumatoid arthritis that can begin in people under the age 16 is
referred to as juvenile idiopathic arthritis (formerly juvenile
rheumatoid arthritis).

Effect of Omega 3 fatty acids:
Terms used RA(rheumatoid arthritis), PUFA-(poly unsaturated
fatty acids),
EPA(eicosapentaenoic acid), DHA- (docosahexaenoic acid).
Putative agents have been proposed, the most common being an
infectious agents or any physical damage which may trigger a
persistent immune response that causes an irreversible damage to
tendons and joints by sustaining the infiltration of activated
macrophages, T lymphocytes and plasma cells into the synovium
and the proliferation of synovial cells.
But there is still little understanding, so as to why the
inflammation persists in such a manner, and as well why the high
Click here to go at the top

7
19-09-2014

intake of fish, olive oil, and cooked vegetables confer a protective
affect against the development of Rheumatoid Arthritis.
The current evidence and the biological plausibility of the
potential anti-inflammatory and therapeutic effects of omega-3
PUFA fatty acids in Rheumatoid arthritis-
The action of dietary fatty acids on RA has been investigated in a
number of in-vitro and animal studies. Inbred strains of mice
developing spontaneous autoimmune disease have been used as
models. In mice that are strongly predisposed genetically to
systemic inflammatory diseases, a high omega-3 PUFA diet
showed a marked preventive effect, but a weaker therapeutic effect
on established diseases. Mice treated with fish oil experienced a
delay in the onset(mean 34 day versus 25 day), a reduced incidence
(69% versus 93%) and severity (mean peak severity score 6.7
versus 9.8) of type II collagen induced arthritis when compared
with those fed with vegetable oil.
However, not all animal studies portrayed beneficial effects: type
II collagen-induced arthritis worsened in animals fed fish oil
compared with those fed beef tallow.
The effects of omega-3 PUFA obtained from fish oil on the antigen
presentation, T-cell reactivity, inflammatory lipid and peptide
mediator production suggests that in animal models these fatty
acids may have a role in decreasing the risk of development of RA.
Most findings suggested the use of purified EPA and DHA, but
those investigating the effects of a mixture of EPA and DHA (2
major omega-3 PUFA constituents of fish oil), found the mixture
more effective than either fatty acids. In another study both EPA
and DHA were used, which ultimately suppressed streptococcal
cell wall-induced arthritis in rats, with EPA being more effective.
If EPA has been shown to inhibit the proliferation of human
synovial lymphocytes, the ideal reported effects of EPA and DHA
are the inhibition of T lymphocytes proliferation and IL-2
production.EPA and DHA also inhibit the cytokine-induced up
regulation of adhesion molecules on the surface of cultured
endothelial cells, and finally decreases the binding of leucocytes to
Click here to go at the top

8
19-09-2014

endothelial cells, and reduces the production of IL-1beta and TNF-
alpha by human monocytes and of IL-6 by rat macrophages.
Human neutrophils, monocytes and mouse macrophages cultured
with EPA or DHA showed reduced superoxide synthesis, low
cytokine-induced cell-surface expression of HLA-DR and HLA-DP
complexes and low cytokine-induced cell-surface expression of
major histocompatibility complex II, respectively. Human
monocytes cultured with EPA or DHA have reduced capability to
present antigen to autologous lymphocytes. Additionally, bovine
chondrocytes cultured with ALA showed a marked decrease in the
cytokine-mediated induction of the COX-2 expression, TNF alpha
and IL-1 alpha genes.
It is to be noted that, ALA (but not palmitic, oleic or linoleic
acids), inhibited the cytokine-mediated up regulation of
aggrecanase activity and aggrecanase gene expression.
Aggrecanases breakdown and degrade the cartilage proteoglycan
and their expression in cartilage is not regulated in response to the
pro-inflammatory cytokines TNF-alpha and IL-1alpha. EPA and
DHA exhibited the same effects as ALA.
However, it has not been clear whether the reported actions of
omega-3 PUFA are due to direct effects of the fatty acids
themselves on COX-2, cytokine and aggrecanase gene expression,
or whether they are eicosanoid-mediated effects. Whatever the
mechanism, it appears that omega-3 PUFA can act within cells to
decrease actions that lead to joint chronic inflammation and
destruction.
Preclinical evidence of anti-inflammatory action of PUFA, i.e.
reduced synthesis of cytokines, eicosanoids and other
inflammatory stimulating factors, on the synovial cells of RA
patients and animal models, several authors investigated whether
dietary PUFA may reduce the inflammatory markers and the
activity of cartilage degradative enzymes in patients with RA.
Whether there are conflicting results concerning the effects of
omega-3 PUFA on cytokine production in ex-vivo studies, some
beneficial effects of dietary fish oil supplementation, in particular
Click here to go at the top

9
19-09-2014

EPA and DHA, have demonstrated on inflammatory cytokines in
healthy humans and patients with RA.
An ex-vivo decreased TNF-alpha and IL-1 synthesis by monocytes
and lipopolysaccharide (LPS)-induced IL-1 production by
monocytes was found in RA patients supplemented with
EPA+DHA (5.9 and 2.9 gr/d), while no effect was obtained on
concanavallin A (ConA)-induced IL-2 production and ConA- or
phytohemagglutinin (PHA)-induced lymphocyte proliferation.
In active RA patients, a decreased soluble TNF-alpha receptor and
C-reactive protein levels were observed after supplementation
with EPA+ DHA (3.4gr/d) and low omega-6 PUFA for 18 weeks,
while the reduction in serum IL-6 and TNF-alpha became
significant at 24 weeks. Similarly, a reduction of the IL-1 serum
concentrations was obtained in RA patients supplemented with
EPA+DHA (3.2 and 7.1 g/d). However, serum IL-6, IL-8 and IL-2
concentrations were unchanged following high dose of EPA+ DHA
(7.1g/d), and no effect on serum TNF-alpha concentrations was
found after increasing fish oil consumption (EPA+ DHA
3.2gr/day[139], 3.4 gr/day[133], 4.2 gr/day[141], 7.1 gr/day.
Some of the biochemical markers relevant to inflammatory
symptoms and Cardiovascular risk were recently evaluated in early
RA patients on disease-modifying antirheumatic drugs (DMARD)
treatment and fish oil (4-4.5 g of EPA plus DHA) over a 3-year
observation period. In patients who were compliant with the
therapy and whose plasma EPA level was > 5% of total plasma
phospholipid fatty acids, the index of Arachidonic acid availability
for eicosanoid synthesis was 30% lower in platelets and 40% lower
in PBMC of the fish oil compared to the no fish oil group.
Correspondingly, there was also mean 35% decrease in platelet
TXB2 production and 41% decrease in lipopolysaccharide
stimulated PBMC synthesis of PGE2 in the fish oil compared to
the no fish oil group.
Similar kind of differences in plasma triglycerides, High density
lipoprotein, cholesterol, and total cholesterol/HDL ratio were also
seen in group treated with fish oil at 3 years but not the non fish oil
Click here to go at the top

10
19-09-2014

group. Altogether, the studies concerned with the anti-
inflammatory proprieties of fish oil use in RA patients provided
some biologic plausibility for the benefits of dietary habits on
inflammatory markers. However, the clinical response to fish-oil
supplements was not investigated in the majority of the studies,
while in others it was modest and somehow not consistent with
changes in inflammatory markers, suggesting that disease-specific
clinical outcomes might be a more sensitive marker of anti-
inflammatory effects of EPA+DHA than inflammatory cytokines.
Omega 3 fatty acids in diet in order to minimize the risk of RA:
There is no special diet or diet "cure" for rheumatoid arthritis.
Hundreds of years ago, it was thought that "night-shade" foods,
such as tomatoes, would aggravate rheumatoid arthritis. This is no
longer accepted as true.
Nevertheless, there is still existence of some home remedies that
may be helpful, although these are not considered as potent or
effective as disease-modifying drugs. Fish oils, such as in salmon,
and omega-3 fatty acids supplements have been shown to be
beneficial in some short-term studies in rheumatoid arthritis. This
suggests that there may be benefits by adding more fish to the diet,
such as in the popular Mediterranean diet.
The anti-inflammatory effects of curcumin(a constituent of
turmeric), used widely as spice ingredient in curry, may be
beneficial in reducing symptoms of rheumatoid arthritis.
Supplements such as calcium and vitamin D are used to prevent
osteoporosis in patients with rheumatoid arthritis. Folic acid is
used as a supplement to prevent side effects of methotrexate
treatment of rheumatoid arthritis. Alcohol is minimized or avoided
in rheumatoid arthritis patients taking methotrexate.
There is no evidence that gluten bothers rheumatoid arthritis. For
those who are definitely sensitive to gluten (wheat, barley, and
rye), the gluten-free diet can prevent poor intestinal absorption of
important nutrients because the small intestines can become
inflamed in these individuals. Bowel inflammation can be
Click here to go at the top

11
19-09-2014

detrimental for those also affected by rheumatoid arthritis if they
become deficient in nutrients, such as vitamin D and folate.
The benefits of cartilage preparations such as glucosamine and
chondroitin for rheumatoid arthritis remain unproven.
Symptomatic pain relief can often be achieved with
oral acetaminophen (Tylenol) or over-the-counter topical
preparations, which are rubbed into the skin. Antibiotics, in
particular the tetracycline drug minocycline (Minocin), have been
tried for rheumatoid arthritis recently in clinical trials. Early
results have demonstrated mild to moderate improvement in the
symptoms of arthritis. Minocycline has been shown to impede
important mediator enzymes of tissue destruction, called
metalloproteinases, in the laboratory as well as in humans.
The areas of the body other than the joints that are affected by
rheumatoid inflammation are treated individually. Sjgren's
syndrome can be helped by artificial tears and humidifying rooms
in the home or office. Medicated eyedrops, cyclosporine
ophthalmic drops (Restasis), are also available to help the dry
eyes in those affected. Regular eye checkups and early antibiotic
treatment for infection of the eyes are important. Inflammation of
the tendons (tendinitis), bursae (bursitis), and rheumatoid
nodules can be injected with cortisone. Inflammation of the lining
of the heart and/or lungs may require high doses of oral cortisone.
Proper regular exercise is important in maintaining joint mobility
and in strengthening the muscles around the joints. Swimming is
particularly helpful because it allows exercise with minimal stress
on the joints. Physical and occupational therapists are trained to
provide specific exercise instructions and can offer splinting
supports. For example, wrist and finger splints can be helpful in
reducing inflammation and maintaining joint alignment. Devices
such as canes, toilet seat raisers, and jar grippers can assist in the
activities of daily living. Heat and cold applications are modalities
that can ease symptoms before and after exercise.
Surgery may be recommended to restore joint mobility or repair
damaged joints. Doctors who specialize in joint surgery are
Click here to go at the top

12
19-09-2014

orthopaedic surgeons. The types of joint surgery range
from arthroscopy to partial and complete replacement of the joint.
Arthroscopy is a surgical technique whereby a doctor inserts a
tube-like instrument into the joint to see and repair abnormal
tissues.
Total joint replacement is a surgical procedure whereby a
destroyed joint is replaced with artificial materials. For example,
the small joints of the hand can be replaced with plastic material.
Large joints, such as the hips or knees, are replaced with metals.
Finally, minimizing emotional stress can help improve the overall
health in people with rheumatoid arthritis. Support and
extracurricular groups provide those with rheumatoid arthritis
time to discuss their problems with others and learn more about
their illness.
Omega 3 fatty acids and its uses-
Typical use-
Used as an adjunct to diet to reduce triglyceride(TG) levels in
adult patients with severe(>500mg/dL) hypertriglyceridemia.
Side effects-
eructation, dyspepsia, taste perversion.
Mechanism of action-
Omega-3-fatty acids causes inhibition of acyl-CoA:1,2-
diacylglycerol acyltransferase, increased mitochondrial and
peroxisomal P-oxidation in the liver, decreased lipogenesis in the
liver, and increased plasma lipoprotein lipase activity and reduce
the synthesis of triglycerides (TG) in the liver because EPA and
DHA are poor substrates for the enzymes responsible for TG
synthesis, and EPA and DHA inhibit esterification of other fatty
acids.
Few tradenames-
Seacod Activ (Aventis Pharma India Ltd)
Thrive (Elder Pharmaceuticals Ltd)
Glacex Tab (Allenburys Glaxo Smithkline)
Evion Forte (Merck)

Click here to go at the top

13
19-09-2014

Some drugs for Rheumatiod arthritis medication(that are
under clinical trials)-





Anurag Chanda
Student, GNIPST
B.Pharm, 4
th
Year



Click here to go at the top

14
19-09-2014

DISEASE RELATED BREAKING NEWS
Enterovirus D68 in the United States of
America: (17
th
September, 2014)
As of 16 September 2014, 130 laboratory-confirmed cases of EV-
D68 have been reported in 12 US states Alabama, Colorado,
Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Missouri,
New York, Oklahoma, and Pennsylvania. Investigations into
suspected clusters in many other states are ongoing.Read more

UPCOMING EVENTS
5
th
International Conference on Stem Cells and Cancer 2014, JNU
Convention Centre, New Delhi, India from 8-10 November, 2014

DRUGS UPDATES
FDA Approves Movantik (naloxegol) for Opioid-
Induced Constipation: (16
th
September, 2014)
Opioids are a class of drugs that are used to treat and manage pain.
A common side effect associated with the use of these drugs are
that they reduce the gastrointestinal tracts motility, making
bowel movements difficult and causing patients to strain, have
hard or lumpy stools or experience a sensation of incomplete
evacuation. Movantik belongs to a class of drugs called
peripherally acting opioid receptor antagonists, which are used to
decrease the constipating effects of opioids. Read more

CAMPUS NEWS
Today, on 5
th
September, 2014 the students of GNIPST have
arranged a wonderful Teachers Day Programme. On behalf of all
the teachers of GNIPST I would like to thank our beloved
students.
Click here to go at the top

15
19-09-2014

The Freshers welcome programme was held on 14
th
August, 2014.
Welcome 1
st
year students.
We congratulate the following M.Pharm. final year students who
have made their positions in different pharmaceutical companies.
Anirban Banerjee (Emami Ltd.)
Mahender Roy (Stadmed private Ltd.)
We congratulate the following B.Pharm. final year students for
their success.
Samadrita Mukherjee (Abbott India Ltd.)
Suman Sarkar (Tata Medical Centre-Apollo Pharmacy)
Shrewashee Mukherjee (Fresenius Kabi-Parenteral Nutrition)
Avishek Naskar (Glaxo SmithKline-Marketing)
Bappaditya Manik (USV Limited)
Sarbani Das (Nutri Synapzz-Marketing)
Ankita Roy (Nutri Synapzz-Marketing)
Rahul Mitra (B M Pharmaceuticals-Production)
The following B.Pharm. final year students have qualified, GPAT-
2014. We congratulate them all.
Utsha Sinha
Satarupa Bhattacharya
Sandipan Sarkar
Purbali Chakraborty
Reminiscence, 2014(GNIPST Reunion) was held in College
campus on 2
nd
February,2014.
1
st
Annual Sports of GNIPST was held on 3
rd
February,2014 in
College campus ground.
An industrial tour and biodiversity tour was conducted in Sikkim
for B.Pharm and B.Sc. students under the supervision of Mr. Asis
Bala, Ms. Jeentara Begum and Ms. Moumita Chowdhury.
Click here to go at the top

16
19-09-2014

B.Pharm 3
rd
year won the GNIPST Football Champions trophy,
2013. B.Pharm 3
rd
year won the final match 1-0 against B.Pharm 2
nd

year. Deep Chakraborty was the only scorer of the final.

STUDENTS SECTION
WHO CAN ANSWER FIRST????
Which pharmaceutical additive is also
coded with E468?
The springing tiger is the biography of
which famous person?

Answer of Previous Issues Questions:
A) Helen Keller
B) Selim Durani
Identify the person

Answer of Previous Issues Image:
Helen Keler


Click here to go at the top

17
19-09-2014

Send your thoughts/
Quiz/Puzzles/games/write-ups or any other
contributions for Students Section&
answers of this Section at gnipstbulletin@gmail.com

EDITORS NOTE
It is a great pleasure for me to publish the 4
th
issue of 37
th
Volume
of GNIPST BULLETIN. All the followers of GNIPST BULLETIN
are able to avail the bulletin through facebook account GNIPST
bulletin I am very much thankful to all the GNIPST members and
readers who are giving their valuable comments, encouragements
and supports. I am also thankful to Dr. Abhijit Sengupta, Director
of GNIPST for his valuable advice and encouragement. Special
thanks to Dr. Prerona Saha, Mr. Debabrata Ghosh Dastidar
and Mr. Soumya Bhattacharya for their kind co-operation and
technical supports. Thank you Mr. Soumya Bhattacharya for the
questionnaires of the student section. An important part of the
improvement of the bulletin is the contribution of the readers. You
are invited to send in your write ups, notes, critiques or any kind of
contribution for the forthcoming special and regular issue.
ARCHIVE
Students of GNIPST organized pre puja celebration programme,
Saaranya on 7
th
October, 2013 in college Auditorium.
GNIPST organized a garment distribution programme on 28
th

September, 2013 at Dakshineswar Kali Temple and Adyapith,
Kolkata. On this remarkable event about hundred people have
Click here to go at the top

18
19-09-2014

received garments. More than hundred students and most of the
faculties participated on that day with lot of enthusiasm.
GNIPST celebrated World Heart Day (29
th
September) and
Pharmacists Day (25
th
September) on 25
th
and 26
th
September,
2013 in GNIPST Auditorium. A seminar on Violence against
woman and female foeticide was held on GNIPST Auditorium on
25
th
September organized by JABALA Action Research
Organization. On 26
th
September an intra-college Oral and Poster
presentation competition related to World Pharmacists day and
Heart day was held in GNIPST. Ms. Purbali Chakraborty of
B.Pharm 4
th
year won the first prize in Oral Presentation. The
winner of Poster presentation was the group of Ms. Utsa Sinha,
Mr. Koushik Saha and Mr. Niladri Banerjee (B.Pharm 4
th
year). A
good number of students have participated in both the
competition with their valuable views.
Teachers day was celebrated on 5
th
September, 2013 by the
students of GNIPST in GNIPST Auditorium.
Azalea (exotic flower ) , the fresher welcome programme for
newcomers of GNIPST in the session 2013-14 was held on 8
th

August in GNIPST Auditorium.
One day seminar cum teachers development programme for
school teachers on the theme of Recent Trends of Life Sciences
in Higher Education organized by GNIPST held on 29
th
June,
2013 at GNIPST auditorium. The programme was inaugurated by
Prof . Asit Guha, Director of JIS Group, Mr. U.S. Mukherjee, Dy
Director of JIS Group and Dr. Abhijit Sengupta, Director cum
Principal of GNIPST with lamp lighting. The programme started
Click here to go at the top

19
19-09-2014

with an opening song performed by the B.Pharm students of this
institute. The seminar consists of a series of lectures, video
presentations and poster session. On the pre lunch session 4
lectures were given by Dr. Lopamudra Dutta, Mr. Debabrata
Ghosh Dastidar, Ms. Swati Nandy and Ms. Tamalika Chakraborty
respectively. On their presentation the speakers enlighten the
recent development of Pharmacy, Genetics and Microbiology and
their correlation with Life Sciences. On the post lunch session, Ms.
Saini Setua and Ms. Sanchari Bhattacharjee explained the recent
development and career opportunities in Biotechnology and
Hospital Management. The programme was concluded with
valedictory session and certificate distribution.
About 50 Higher secondary school teachers from different
schools of Kolkata and North& South 24 Parganas district of West
Bengal participated in this programme. A good interactive session
between participants and speakers was observed in the seminar.
The seminar was a great success with the effort of faculties, staffs
and students of our Institute. It was a unique discussion platform
for school teachers and professional of the emerging and newer
branches of Life Science.
The general body meeting of APTI, Bengal Branch has been
conducted at GNIPST on 15
th
June, 2012. The program started with
a nice presentation by Dr. Pulok Kr. Mukherjee, School of Natural
Products, JU on the skill to write a good manuscript for
publication in impact journals. It was followed by nearly two hour
long discussion among more than thirty participants on different
aspects of pharmacy education. Five nonmember participants
applied for membership on that very day.
Click here to go at the top

20
19-09-2014

GNIPST is now approved by AICTE and affiliated to WBUT for
conducting the two years post graduate course (M.Pharm)
in PHARMACOLOGY. The approved number of seat is 18.
The number of seats in B.Pharm. has been increased from 60 to
120.
AICTE has sanctioned a release of grant under Research
Promotion Scheme (RPS) during the financial year 2012-13to
GNIPST as per the details below:
a. Beneficiary Institution: Guru Nanak Institution of Pharmaceutical
Science & Technology.
b. Principal Investigator: Dr. LopamudraDutta.
c. Grant-in-aid sanctioned:Rs. 16,25000/- only
d. Approved duration: 3 years
e. Title of the project: Screening and identification of potential
medicinal plant of Purulia & Bankura districts of West Bengal
with respect to diseases such as diabetes, rheumatism, Jaundice,
hypertension and developing biotechnological tools for enhancing
bioactive molecules in these plants.
Click here to go at the top

21

Vous aimerez peut-être aussi